Results
1 -
10 of
10
(Click
here to explore results)
- Flavopiridol as cyclin dependent kinase (CDK) inhibitor: a review. Aakash Deep, Rakesh Kumar Marwaha, Minakshi Gupta Marwaha, Jyoti, Rimmy Nandal, Arun Kumar Sharma
, New J. Chem.
, 2018
, 42
, 18500
- Online informatics resources to facilitate cancer target and chemical probe discovery. Xuan Yang, Haian Fu, Andrey A. Ivanov
, RSC Med. Chem.
, 2020
, 11
, 611
- CDK9 inhibitors in cancer research. Zhi Huang, Tianqi Wang, Cheng Wang, Yan Fan
, RSC Med. Chem.
, 2022
, 13
, 688
- Novel tacrine derivatives as potential CDK9 inhibitors with low cholinesterase inhibitory properties: design, synthesis, and biological evaluation. Wenwu Liu, Yaoguang Huang, Limeng Wu, Wenjie Liu, Xiaowen Jiang, Zihua Xu, Qingchun Zhao
, New J. Chem.
, 2022
, 46
, 19342
- Direct N–H/α,α,β,β-C(sp3)–H functionalization of piperidine via an azomethine ylide route: synthesis of spirooxindoles bearing 3-substituted oxindoles. Yanlong Du, Aimin Yu, Jiru Jia, Youquan Zhang, Xiangtai Meng
, Chem. Commun.
, 2017
, 53
, 1684
- Chemical fragment-based CDK4/6 inhibitors prediction and web server. Ling Wang, Yecheng Li, Mengyan Xu, Xiaoqian Pang, Zhihong Liu, Wen Tan, Jun Xu
, RSC Adv.
, 2016
, 6
, 16972
- SAR study on N
2,N
4-disubstituted pyrimidine-2,4-diamines as effective CDK2/CDK9 inhibitors and antiproliferative agents. Liandong Jing, Yanbo Tang, Masuo Goto, Kuo-Hsiung Lee, Zhiyan Xiao
, RSC Adv.
, 2018
, 8
, 11871
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612
- Natural products to drugs: natural product-derived compounds in clinical trials. Mark S. Butler
, Nat. Prod. Rep.
, 2008
, 25
, 475
- Recent advances in the synthesis of natural products containing the phloroglucinol motif. Yee Lin Phang, Song Liu, Changwu Zheng, Hongxi Xu
, Nat. Prod. Rep.
, 2022
, 39
, 1766